Actemra SC drug use results survey

Actemra SC drug use results survey - Actemra SC drug use results survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011102

Enrollment

1000

Registered

2013-07-04

Start date

2013-07-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have no previous medical history of Actemra SC for RA.

Exclusion criteria

Exclusion criteria: No criteria

Design outcomes

Primary

Measure	Time frame
Adverse reaction incidence Changes in Disease Activity Score 28 (DAS28-ESR) and Clinical disease activity index (CDAI) at week 12, 26.	—

Countries

Japan

Contacts

Public ContactMakoto Nomura

Chugai Pharmaceutical Co. Ltd. Pharmacovigilance Dept.

nomuramkt@chugai-pharm.co.jp03-3273-0905

Outcome results